Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report



Delayed neuromuscular recovery after use of sugammadex in a patient with amyotrophic lateral sclerosis: a case report

Tsong-Bih Chang, Jin Huh.

Abstract
This case report describes delayed muscular recovery after general anesthesia using rocuronium and sugammadex in a patient with amyotrophic lateral sclerosis (ALS).
A 62-year-old woman with ALS with bulbar involvement underwent ureteroscopic ureterolithotomy. We performed general anesthesia using propofol, rocuronium and sevoflurane with standard and neuromuscular monitoring. Rocuronium was administered at a dose of 20 mg (0.38 mg/kg) to facilitate endotracheal intubation, and anesthesia was maintained with sevoflurane in the range of 1-3 vol%. After the procedure, 100 mg of sugammadex (1.92 mg/kg) was administered and a train-of-four (TOF) ratio >0.9 was observed in 80 s. However, the muscle strength was not the same as the preoperative level and tidal volume was inadequate for extubation. No further improvement in muscle strength was observed after administration of an additional 100 mg of sugammadex. The patient was transferred to the intensive care unit and pressure support ventilation was applied. Muscle strength was checked periodically and tracheal extubation was performed based on complete neuromuscular recovery to preanesthetic level 4 h later.

Key words: Amyotrophic lateral sclerosis; Sugammadex; Train-of-Four



Similar Articles

SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiology.
Marques RF, Duncan KE
Neural regeneration research. 2022; 17(2): 266-270

Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis.
Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, Shang HF
Neural regeneration research. 2022; 17(4): 875-880

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects.
Rey F, Ottolenghi S, Zuccotti GV, Samaja M, Carelli S
Neural regeneration research. 2022; 17(4): 754-758

MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches.
Martinez B, Peplow PV
Neural regeneration research. 2022; 17(4): 728-740

Ultra-early amplitude decrement after repetitive nerve stimulation supports early neuromuscular junction injury in amyotrophic lateral sclerosis: a prospective cross-sectional study.
Ma JY, Liu XY, Zhang S, Fan DS
Neural regeneration research. 2022; 17(3): 655-660


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites